FI107515B - Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi - Google Patents

Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi Download PDF

Info

Publication number
FI107515B
FI107515B FI930319A FI930319A FI107515B FI 107515 B FI107515 B FI 107515B FI 930319 A FI930319 A FI 930319A FI 930319 A FI930319 A FI 930319A FI 107515 B FI107515 B FI 107515B
Authority
FI
Finland
Prior art keywords
dnp
antigen
liposome
cappe
liposomes
Prior art date
Application number
FI930319A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI930319A (fi
FI930319A0 (fi
Inventor
Nathalie Garcon
Howard R Six
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI930319A publication Critical patent/FI930319A/fi
Publication of FI930319A0 publication Critical patent/FI930319A0/fi
Application granted granted Critical
Publication of FI107515B publication Critical patent/FI107515B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI930319A 1990-07-27 1993-01-26 Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi FI107515B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55896090A 1990-07-27 1990-07-27
US55896090 1990-07-27
US9105231 1991-07-24
PCT/US1991/005231 WO1992002243A1 (en) 1990-07-27 1991-07-24 Liposomes that provide thymic dependent help to weak vaccine antigens

Publications (3)

Publication Number Publication Date
FI930319A FI930319A (fi) 1993-01-26
FI930319A0 FI930319A0 (fi) 1993-01-26
FI107515B true FI107515B (fi) 2001-08-31

Family

ID=24231699

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930319A FI107515B (fi) 1990-07-27 1993-01-26 Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi

Country Status (22)

Country Link
US (1) US5464630A (ja)
EP (1) EP0542923B1 (ja)
JP (1) JP3518866B2 (ja)
KR (1) KR100213851B1 (ja)
CN (1) CN1032236C (ja)
AT (1) ATE157537T1 (ja)
AU (1) AU650299B2 (ja)
CA (1) CA2088163C (ja)
DE (1) DE69127545T2 (ja)
DK (1) DK0542923T3 (ja)
ES (1) ES2106088T3 (ja)
FI (1) FI107515B (ja)
GR (1) GR3025377T3 (ja)
HK (1) HK1008304A1 (ja)
IE (1) IE912535A1 (ja)
IL (1) IL98935A (ja)
NO (1) NO311167B1 (ja)
NZ (1) NZ239072A (ja)
PT (1) PT98470B (ja)
RU (1) RU2107493C1 (ja)
WO (1) WO1992002243A1 (ja)
ZA (1) ZA915755B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879685A (en) * 1991-05-08 1999-03-09 Schweiz, Serum- & Impfinstitut Bern Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6004534A (en) * 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
AU3541495A (en) * 1994-09-01 1996-03-22 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
US6060082A (en) * 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
AUPO732997A0 (en) * 1997-06-12 1997-07-03 Csl Limited Ganglioside immunostimulating complexes and uses thereof
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
JP4685350B2 (ja) * 2001-07-26 2011-05-18 オタゴ イノベイション リミティド 抗原性組成物
WO2007039583A1 (en) * 2005-09-30 2007-04-12 Lipoxen Technologies Limited Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
RU2480479C1 (ru) * 2011-11-01 2013-04-27 Елена Викторовна Свирщевская Гетерологичный пептидный мини-антиген в составе полимерной частицы для создания противоаллергенной вакцины
DK2800762T3 (en) 2012-01-03 2018-04-16 Us Health NATIVE AND AGONISTIC CTL EPITOPES OF THE MUC1 TUMOR ANTIGEN
WO2015061416A2 (en) 2013-10-23 2015-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
JP7048482B2 (ja) 2015-08-03 2022-04-05 アメリカ合衆国 Ｂｒａｃｈｙｕｒｙ欠失変異体、Ｂｒａｃｈｙｕｒｙ欠失変異体をコードする非酵母ベクター、及びそれらの使用
AU2017355564B2 (en) 2016-11-07 2022-04-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of agonist epitopes of the human papillomavirus
US20220009980A1 (en) 2018-11-14 2022-01-13 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Tp5, a peptide inhibitor of aberrant and hyperactive cdk5/p25 as treatment for cancer
WO2021150713A2 (en) 2020-01-21 2021-07-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs)
EP4093432A1 (en) 2020-01-21 2022-11-30 The United States of America, as represented by the Secretary, Department of Health and Human Services Human immunogenic epitopes of hemo and hhla2 human endogenous retroviruses (hervs)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4196191A (en) * 1975-09-29 1980-04-01 Burroughs Wellcome Co. Biological preparations
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
US4708933A (en) * 1984-06-12 1987-11-24 Leaf Huang Immunoliposome assay-methods and products
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.

Also Published As

Publication number Publication date
NO930202D0 (no) 1993-01-21
CA2088163A1 (en) 1992-01-28
FI930319A (fi) 1993-01-26
JP3518866B2 (ja) 2004-04-12
KR100213851B1 (ko) 1999-08-02
ES2106088T3 (es) 1997-11-01
ZA915755B (en) 1993-02-24
WO1992002243A1 (en) 1992-02-20
PT98470B (pt) 1998-02-27
EP0542923B1 (en) 1997-09-03
US5464630A (en) 1995-11-07
RU2107493C1 (ru) 1998-03-27
IL98935A0 (en) 1992-07-15
NO930202L (no) 1993-01-21
EP0542923A1 (en) 1993-05-26
AU8759791A (en) 1992-03-02
DE69127545D1 (de) 1997-10-09
NO311167B1 (no) 2001-10-22
CN1032236C (zh) 1996-07-10
IE912535A1 (en) 1992-01-29
DE69127545T2 (de) 1998-01-08
CN1059279A (zh) 1992-03-11
PT98470A (pt) 1992-06-30
IL98935A (en) 1994-01-24
HK1008304A1 (en) 1999-05-07
ATE157537T1 (de) 1997-09-15
CA2088163C (en) 2003-06-17
AU650299B2 (en) 1994-06-16
FI930319A0 (fi) 1993-01-26
GR3025377T3 (en) 1998-02-27
JPH06502630A (ja) 1994-03-24
EP0542923A4 (ja) 1994-04-13
NZ239072A (en) 1997-06-24
DK0542923T3 (da) 1997-10-13

Similar Documents

Publication Publication Date Title
FI107515B (fi) Menetelmä antigeenin liposomaalisen immunogeenisen kantajan valmistamiseksi
US4565696A (en) Production of immunogens by antigen conjugation to liposomes
AU627226B2 (en) Influenza vaccine and novel adjuvants
EP0180564B1 (en) Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
EP0939647B1 (en) Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
Lowell et al. Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants.
Alving et al. Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen
Ragupathi et al. A novel and efficient method for synthetic carbohydrate conjugate vaccine preparation: synthesis of sialyl Tn-KLH conjugate using a 4-(4-N-maleimidomethyl) cyclohexane-1-carboxyl hydrazide (MMCCH) linker arm
Garcon et al. Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens.
US5049390A (en) Liposome containing immunotherapy agents for treating IgE mediated allergies
Boeckler et al. Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes
EP0117367A1 (en) Synthetic heat-stable enterotoxin polypeptide and multimers thereof
JPH09505056A (ja) ヒトガストリン１７に対する改良された免疫原性組成物
JP2001523216A (ja) 新規のアジュバント組成物と、それからなるワクチン製剤
Boeckler et al. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes
US20080038291A1 (en) Method to reduce the physiologic effects of drugs on mammals
NZ230424A (en) Liposomal composition comprising an externally disposed antigen
HRP930658A2 (en) Improved vaccine compositions
Teerlink et al. Synergistic effect of detergents and aluminium phosphate on the humoral immune response to bacterial and viral membrane proteins
WO1990001947A1 (en) Affinity associated vaccine
Leibl et al. Adjuvant/carrier activity of inactivated tick-borne encephalitis virus
EP0517743A1 (en) Improved immunogenic compositions
Pietrobon et al. Liposomes that provide T-dependent help to weak antigens (T-independent antigens)
Frisch et al. Synthetic Peptide–Based Highly Immunogenic Liposomal Constructs
JPH0912480A (ja) 抗原結合リポソーム型ワクチン